SynapCell is a biotechnology company whose mission is to support drug developers in discovering new treatments for CNS disorders. We help our clients worldwide move forward in their R&D programs by identifying and qualifying the therapeutic potential of their molecules on Epileptic, Cognitive, Movement or Neurodegenerative disorders. Studying neuronal network oscillations has allowed us to highlight unbiased, robust and stable biomarkers of brain dysfunctions. To achieve that, our experts have developed innovative and predictive solutions based on EEG in a Bedside to Bench translational context applied to Drug Discovery.

Our offer is based on solid foundations, giving you confidence and assurance to MAKE DECISIONS.